Efavirenz also acts as a pregnane×receptor agonist that promotes dyslipidaemia and hypercholesteraemia.42 NNRTIs promote MetS by reducing insulin sensitivity through their proinflammatory effects. This evidence concerns the gene INS and inherited lipid metabolism disorder.